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Abstract
Objectives: Bovine paratuberculosis is a devastating infection with Mycobacterium avium subspecies paratuberculosis that
ultimately results in death from malnutrition. While the infection is characterized by a long (2–4 years) subclinical phase
with immune activation, ultimately host defense mechanisms fail and the bacteria spread from the small intestine to other
organs. Since both the gastrointestinal tract and liver are essential for the biosynthesis of structural glycerophospholipids, we
investigated the circulating levels of these lipids in field infections and experimentally infected cattle.
Methods: Serum lipidomics of control and M. avium subspecies paratuberculosis–infected cattle were performed utilizing
high-resolution mass spectrometry.
Results: In M. avium subspecies paratuberculosis–positive cattle, demonstrating clinical signs, we monitored large decreases
in the levels of circulating phosphocholine-containing lipids. These included phosphatidylcholines, choline plasmalogens, and
sphingomyelins. Next, we monitored the time course of these lipid alterations in experimentally infected calves and found
that altered lipid levels were only detected in cattle with clinical signs of infection.
Conclusions: Our data indicate that altered availability of choline-containing lipids occurs late in the disease process and is
most likely a result of malnutrition and altered biosynthetic capacities of the liver and gastrointestinal tract. Alterations in the
bioavailability of these critical structural lipids presumably contributes to the demise of M. avium subspecies paratuberculosis–
infected cattle. In light of increasing concern that M. avium subspecies paratuberculosis may be a zoonotic bacterium that
contributes to the development of Crohn’s disease and multiple sclerosis, our data also have human clinical relevance.
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Paratuberculosis (PTB) is an enteritis of ruminants that
involves infection with Mycobacterium avium subspecies
paratuberculosis (MAP) generally shortly after birth through
ingestion of bacteria shed in the feces of infected animals or
colostrum from and infected dam. Affected cattle have a long
(>2 years) subclinical phase prior to the emergence of clinical signs including persistent diarrhea, weight loss, and
decreased milk production.1,2 The emergence of the clinical
phase of the disease is characterized by a transition of Th1
cell-mediated immune responses to Th2 immune responses.3
This shift in immune regulation results in alterations in the
composition of the gastrointestinal (GI) flora,4 severe granulomatous enteritis,5 and liver damage.6,7
Proteomics,8,9 metabolomics,10 transcriptomics,11,12 and
microRNA13,14 studies of PTB have supported an altered

immune response in infected cattle. Proteomics studies have
reported an induction of acute phase reactants in the serum of
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infected cattle8 further supporting altered liver function in
PTB. In contrast, there have not been any studies of the lipidome in PTB, except for a transcriptomics study that detected
altered enzyme function regulating cholesterol metabolism.15,16 Since both the liver and GI epithelium are important
sources of glycerophospholipids17,18 and are compromised in
PTB, we undertook a non-targeted high-resolution mass
spectrometric lipidomics analysis19–21 of serum in MAPinfected cattle.

Materials and methods
Cattle: pilot study
Serum and fecal samples were submitted from clinical cases
by the practitioners for diagnosis of MAP. Enzyme-linked
immunosorbent assay (ELISA) (IDEXX MAP ELISA Ab
Test kit, Westbrood, Maine) on serum samples and real-time
polymerase chain reaction (PCR) assay (rt-PCR) (VetMAX™Gold MAP Detection Kit, Thermofisher scientific, Waltham,
Massachusetts) on fecal samples were carried out by using
commercial kits. All testing was performed at the University
of Kentucky Veterinary Diagnostic Laboratory (UKVDL), a
fully accredited laboratory by American Association of
Veterinary Laboratory Diagnosticians (AAVLD). Serum and
fecal samples from three MAP-negative and three MAP- positive cattle were stored at −80oC prior to analyses. The cycle
threshold (Ct) of rt-PCR is used as an estimate of the amount
of MAP DNA in the fecal material and gives a general idea
about shedding status of the animal. The Ct was used as an
estimate of the amount of MAP DNA in the fecal material.
Generally, the lower the number, the more DNA in the fecal
material. MAP DNA can then be correlated to the number of
organisms shed in the fecal material as per the United States
Department of Agriculture (USDA) guidelines: <25 Ct = Very
Heavy Fecal Shedder; <30 Ct = Heavy Fecal Shedder; <33
Ct = Moderate Fecal Shedder; <36 Ct = Light Fecal Shedder;
<40 Ct = Suspect Fecal Shedder. The three positive cattle
were heavy shedders. They were angus cattle from different
farms and were approximately 2 years of age.
While the pilot study included only three animals, these
were confirmed MAP-positive cattle that also demonstrated
overt clinical signs. Hence, while the N was small, it was
anticipated to be able to detect any robust alterations in the
serum lipidome.

Cattle: validation study
For the validation study, field samples from 12 MAPnegative cattle and 12 MAP-positive (by ELISA) cattle with
overt signs (excessive diarrhea and weight loss) of Johne’s
disease (>2 years old) were examined. The samples came
from different farms to the University Veterinary Diagnostic
Laboratory. The cattle were mainly 2- to 2.5-year-old angus.
Both serum and fecal MAP DNA analyses and clinical criteria were utilized as described above.
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The N of 12 for the validation study was based on our
prior experience with monitoring the effects of bacterial
infections on the host lipidome. In addition, this was a realworld study in that the samples were submitted to a central
Veterinary Diagnostic Laboratory from different farms.

Cattle: time course study (experimental infection)
To monitor the time course of lipid changes, six control
calves and seven experimentally infected calves9 were monitored from month 0 to month 16. Two of the calves developed clinical signs of Johne’s disease by month 16. The
samples we examined were from the high-dose animals in
the metabolomics study conducted by De Buck et al.9 The
high-dose inoculum (5 × 109 CFU) was deposited at the root
of the tongue with a syringe on 2 consecutive days. Animal
care protocol M09083 covered the experimental infection of
dairy calves with MAP for the purpose of discovering biomarkers of infection by metabolomic profiling and was
approved by the Health Sciences Animal Care Committee of
the University of Calgary.

Lipidomics
Serum samples were vortexed with 1 mL of methanol containing stable isotope internal standards.19–21 Next, 1 mL of
water and 2 mL of methyl-tert-butyl ether were added and
the tubes vigorously shaken at room temperature for 30 min
prior to centrifugation at 4000 xg for 10 min at room temp.
The upper organic layer was isolated and dried by centrifugal vacuum evaporation and dissolved in isopropanol: methanol: chloroform (4:2:1) containing 7 mM ammonium
acetate. The stable isotope internal standards included [2H31]
PtdE 34:1, [2H54]PtdE 28:0, [2H31]PtdC 34:1, [2H54]PtdC
28:0, and bromocriptine as internal standards.
Direct infusion lipidomics utilized high-resolution data
acquisition, with an orbitrap mass spectrometer (Thermo Q
Exactive). In negative ion electrospray ionization (ESI), the
anions of ethanolamine plasmalogens (PlsE), phosphatidylethanolamines (PtdE), lysophosphoethanolamines (LPE),
lysophosphatidic acids (LPA), sphingosine 1-phosphate (S-1P), phosphatidylglycerols (PG), phosphatidylinositols (PI),
and phosphatidylserines (PS). In positive ion ESI, the cations
of choline plasmalogens (PlsC), phosphatidylcholines (PtdC),
lysophosphatidylcholines, and sphingomyelins were quantitated. The cations and anions of bromocriptine were used to
monitor for potential mass axis drift. Between injections, the
transfer line was washed with successive 500 µL washes of
methanol and hexane/ethyl acetate/chloroform (3:2:1). The
monitored ions and parts per million error for altered phosphocholine-containing lipids is presented in Table 1.

Statistical analysis
Semi-quantitative data are presented as R values which represent the ratio of endogenous lipid peak area to the peak
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Table 1. Exact masses, calculated cations, and the ppm mass
error for the cations monitored by high-resolution mass
spectrometry for PtdC and SM.
Biomarker

Exact mass

[M + H]+

ppm

PtdC 38:1
PtdC 38:2
PtdC 38:3
PtdC 38:4
PtdC 38:5
PtdC 38:6
PtdC 40:3
PtdC 40:4
PtdC 40:5
PtdC 40:6
PtdC 40:7
PtdC 40:8
PlsC 36:1
PlsC 36:2
PlsC 36:3
PlsC 36:4
PlsC 36:5
PlsC 36:6
PlsC 38:3
PlsC 38:4
PlsC 38:5
PlsC 38:6
*PlsC 38:7
PlsC 38:8
SM 16:1
SM 17:0
SM 18:0
SM 18:1
SM 24:0
SM 24:1

815.6404
813.6248
811.6091
809.5935
807.5778
805.5622
839.6404
837.6248
835.6091
833.5935
831.5778
829.5622
771.6141
769.5985
767.5829
765.5673
763.5517
761.5361
795.6142
793.5986
791.5829
789.5673
787.5517
785.5360
700.5519
716.5832
730.5989
728.5832
814.6928
812.6772

816.6477
814.6320
812.6164
810.6007
808.5851
806.5694
840.6477
838.6320
836.6164
834.6007
832.5851
830.5694
772.6214
770.6058
768.5902
766.5746
764.5590
762.5434
796.6215
794.6059
792.5902
790.5746
788.5589
786.5433
701.5592
717.5905
731.6062
729.5905
815.7001
813.6845

0.31
0.84
2.18
4.85
5.96
3.04
0.24
0.70
1.49
1.49
1.74
0.92
0.36
0.52
0.96
1.48
1.54
0.98
0.19
0.48
0.65
0.60
0.58
0.30
0.54
1.1
0.99
1.72
0.78
1.29

ppm: parts per million mass error; PtdC: phosphatidylcholines; PlsC:
choline plasmalogens; SM: sphingomyelins.

area of an appropriate internal standard. A Student’s t-test
(Microsoft Excel) was used to determine significant differences in serum levels of metabolites between MAP-infected
animals and controls.

Results

Figure 1. Pilot lipidomics observations for MAP-positive (N = 3)
versus MAP-negative cows (N = 3). The MAP-positive cows had
Ct values of 24.32, 25.06, and 30.26. Data (R) are presented as
the ratio of the peak area of the endogenous lipid to the peak
area of the internal standard (mean ± SD).
*p < 0.01; **p < 0.05.

Pilot lipidomics study: preliminary determination
of decrements in choline-containing lipids

Validation lipidomics study: validation of
decrements in choline-containing lipids

In our pilot study of three control and three infected cattle, we found small to no changes in the serum levels of
PG, PS, PI, PtdE, and PlsE (data not shown). However,
we noted significant and consistent decreases in the circulating pools of PtdC, PlsC, and sphingomyelins. Plots
of these decreases for 36:1 to 36:6 PlsC, 38:1 to 38:6
PtdC, and 16:1 to 24:1 sphingomyelins are presented in
Figure 1.

In a follow-up study of 12 control and 12 infected cattle, we
similarly observed specific decrements in the levels of choline-containing glycerophospholipids and sphingolipids in
infected cattle. Large decrements in circulating levels of
PtdC (Figure 2) and PlsC (Figure 3) were monitored in cattle
demonstrating clinical signs of MAP infection.
With regard to phosphatidylcholine metabolites, lysophosphatidylcholines were decreased while their phospholipase D
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Figure 2. Plasma levels of phosphatidylcholines in PTB positive
versus negative cows (N = 12 per group). Data (R) are presented
as the ratio of the peak area of the endogenous lipid to the peak
area of the internal standard (mean ± SEM).

Figure 3. Plasma levels of choline plasmalogens in PTB positive
versus negative cows (N = 12 per group). Data (R) are presented
as the ratio of the peak area of the endogenous lipid to the peak
area of the internal standard (mean ± SEM).

p values are presented in the brackets.

p values are presented in the brackets.

(PLD) metabolites, LPA and alkyl-acyl phosphatidic acid,
were increased (Figure 4) suggesting that PtdC are extensively degraded and/or their synthesis is decreased with MAP
infection.
Large decrements in circulating levels of sphingomyelins
(Figure 5), another class of choline-containing lipids, were
monitored in our non-targeted lipidomics evaluation of
infected cattle. In the case of sphingomyelin metabolism,
increased levels of S-1-P were monitored (Figure 5). Since
S-1-P is both a precursor and metabolite of sphingomyelins,
it remains to be defined if augmented sphingomyelin metabolism and/or decreased sphingomyelin synthesis occurs with
PTB infection.

group as a whole did not demonstrate any alterations in the
levels of choline-containing lipids (Figure 6) with only one
of the two cows demonstrating clinical signs having decrements in lipid levels at 16 months (35% decrease in PtdC,
50% decrease in PlsC, 31% decrease in sphingomyelins).

Time course study: decrements in
choline-containing lipids only in cattle
demonstrating overt clinical signs
A study of experimentally infected calves was undertaken to
monitor the time course of lipid alterations induced by infection with MAP. Of the seven infected calves, only two developed clinical signs of Johne’s disease by 16 months. The

Discussion
Bacterial infection of the ileal mucosa and lymph nodes by
MAP results in the development of a chronic granulomatous
inflammation but only after a long (months to years) incubation period in cattle. After this long preclinical phase, compositional and functional changes in the gut microbiota,4
along with a shift to a Th2-biased immune response results in
lesions of the intestinal epithelium5,22 and liver.6,7 The
expressions of clinical signs at this stage include treatmentresistant diarrhea, muscle wasting, and decreased milk production.2,3 This phase of the infection has devastating effects
on the health of dairy herds and significant negative economical impact.
A number of “omics” technologies have been utilized in
an attempt to define biomarkers of early disease expression.

Wood et al.
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Figure 6. Serum levels of phosphatidylcholine (PtdC) 36:4 in
experimentally infected (N = 7) and control cows (N = 6) from
time zero and 1 to 16 months post-infection. Data (R) are
presented as the ratio of the peak area of the endogenous lipid to
the peak area of the internal standard (mean ± SEM).

Figure 4. Plasma levels of lysophosphatidylcholines (LPC),
alkyl-acyl phosphatidic acid 34:0 (PeA), and lysophosphatidic acids
(LPA) in infected versus negative cows (N = 12 per group). Data
(R) are presented as the ratio of the peak area of the endogenous
lipid to the peak area of the internal standard (mean ± SEM).
p values are presented in the brackets.

Figure 5. Plasma levels of sphingomyelins and sphingosine
1-phosphate (S-1-P) in PTB positive versus negative cows (N = 12
per group). Data (R) are presented as the ratio of the peak area
of the endogenous lipid to the peak area of the internal standard
(mean ± SEM).
p values are presented in the brackets.

These include metabolomics studies10 of amino acids and
metabolic intermediates that have pointed to alterations in
the gut microbiome while proteomics studies have observed
a general hypoproteinemia, late in the disease process.7–9 At

this stage of the disease, there is widespread destruction of
the mucosal wall of the small intestine and bacterial spread
to the uterus, mammary gland, muscle, and liver.22,23 Elevated
liver and muscle enzymes6,7 also are reflective of liver damage and muscle wasting, respectively. Altered liver immune
function is further supported by elevations in the levels of
circulating acute phase reactants.8
Our lipidomics data from cows demonstrating clinical
signs reveal a profound decrease in the circulating levels of
choline-containing glycerophospholipids and sphingolipids.
The major anatomical sites that supply these lipids to the
bloodstream are the liver and ileal epithelium.17,18 Disruption
of the gut wall will both decrease the absorption of glycerophospholipid and sphingolipid precursors and disrupt the
synthetic capacity of the GI epithelium to synthesize these
lipids. Similarly, with liver lesions in MAP-positive animals,7 the biosynthesis of structural lipids will be negatively
affected. The GI epithelium and the liver are the major
sources of circulating glycerophospholipids and sphingolipids and the dysfunction at these anatomical sites can explain
the decrements in choline-containing lipids that we monitored. In addition, the absorption of choline from the GI tract
may be decreased and altered GI microflora may result in
altered metabolism of choline within the gut.
It should also be noted that MAP has a cell wall rich in
complex lipids and waxes containing mycolic acid.15 It is
possible that reduction of some of these lipids in the cattle
could be due to the fact that the MAP cell wall requires high
amount of these lipids for maintaining the cell wall and for
replication.
In our time course study, no alterations in the circulating
levels of choline-containing lipids were detected in the early
phases of the disease and of the two cows demonstrating
clinical signs at the end of the 17-month study, only one was
advanced enough for us to monitor decreases in the cholinecontaining lipids. These data support the concept that
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disruption of the gut mucosa and liver are responsible for the
observed serum lipid changes in cows demonstrating clinical
signs. However, our lipidomics data do not provide any indices for the early detection of infection.
With the lack of effective vaccines or therapy for latestage infections, control of MAP infection involves herd
management strategies. Therefore, it is imperative to increase
our understanding of the risk factors for MAP infection if
new therapies are to be developed. In this regard, polymorphisms in SLC11A1 represent a significant risk factor for
MAP infection.24–27 SLC11A1 is a divalent metal ion transporter family with polymorphisms having the potential to
alter the levels of metal ions essential for the activity of a
number of enzymes. In this regard, PLD which is activated
by divalent metal ions28 hydrolyzes PtdC and lysophosphatidylcholines to generate phosphatidic acids (PA) and LPA,
respectively. In our lipidomics analyses, we did not monitor
circulating levels of diacyl-phosphatidic acids in control or
infected cows. However, we did monitor significant increases
in alkyl-acyl phosphatidic acid 34:0 and LPA 16:0 and 18:0
(Figure 4). These data, in conjunction with the decreased
levels of the direct precursors of each of these metabolites,
suggest that abnormal SLC11A1 function may contribute to
the monitored decrements in serum choline-containing
lipids.
Our observations also may be of significance to human
health. There is increasing concern that MAP may be a
zoonotic bacterium29 that contributes to the development of
Crohn’s disease30,31 and multiple sclerosis.32 Furthermore,
multiple sclerosis patients with MAP infection31 and Crohn’s
disease patients with MAP infection33 possess polymorphisms in SLC11A1. While these may represent a small subset of patients with these diseases, it suggests that the
contribution of MAP infections to the disease process in
patients with SLC11A1 polymorphisms should be investigated further.
This pilot study is only limited by the small sample size.
The next steps would be to investigate a larger cohort of cattle and to include analysis of SLC11A1 polymorphisms to
evaluate any possible correlation with alterations in cholinecontaining lipids.

Conclusion
MAP infection in cows can result in dysfunctional host-GI
flora interactions and frank lesions of the gut mucosa and
liver. These dysfunctions ultimately result in the emergence
of clinical signs. Our lipidomics data suggest that at this
phase of the disease, tissue pathologies lead to large-scale
decrements in the biosynthesis of essential choline-containing glycerophospholipids and sphingolipids. The contribution of SLC11A1 polymorphisms to altered lipid metabolism
requires further investigation, including in Crohn’s disease
and multiple sclerosis patients with SLC11A1 polymorphisms. Our data also suggest that choline supplementation
may be worthy of investigation in MAP-positive cows.
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